{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:25:52Z","timestamp":1788193552587,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11916-020-00914-3","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T16:03:19Z","timestamp":1608134599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Noninvasive Neuromodulation in Migraine"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0084-4743","authenticated-orcid":false,"given":"Benzion","family":"Blech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaal J.","family":"Starling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,16]]},"reference":[{"issue":"4","key":"914_CR1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/head.13281","volume":"58","author":"R Burch","year":"2018","unstructured":"Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache. 2018;58(4):496\u2013505.","journal-title":"Headache"},{"issue":"8","key":"914_CR2","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/head.12150","volume":"53","author":"DC Buse","year":"2013","unstructured":"Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2013;53(8):1278\u201399.","journal-title":"Headache"},{"issue":"10100","key":"914_CR3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211\u201359.","journal-title":"Lancet"},{"issue":"10","key":"914_CR4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/0333102410370873","volume":"30","author":"DL Nelson","year":"2010","unstructured":"Nelson DL, Phebus LA, Johnson KW, Wainscott DB, Cohen ML, Calligaro DO, et al. Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan. Cephalalgia. 2010;30(10):1159\u201369.","journal-title":"Cephalalgia."},{"issue":"S2","key":"914_CR5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/head.13586","volume":"59","author":"RB Halker Singh","year":"2019","unstructured":"Halker Singh RB, Ailani J, Robbins MS. Neuromodulation for the acute and preventive therapy of migraine and cluster headache. Headache. 2019;59(S2):33\u201349.","journal-title":"Headache"},{"issue":"7","key":"914_CR6","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/brain\/awz134","volume":"142","author":"PJ Goadsby","year":"2019","unstructured":"Goadsby PJ, Wietecha LA, Dennehy EB, Kuca B, Case MG, Aurora SK, et al. Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine. Brain J Neurol. 2019;142(7):1894\u2013904.","journal-title":"Brain J Neurol"},{"issue":"24","key":"914_CR7","doi-asserted-by":"crossref","first-page":"e2222","DOI":"10.1212\/WNL.0000000000006641","volume":"91","author":"B Kuca","year":"2018","unstructured":"Kuca B, Silberstein SD, Wietecha L, Berg PH, Dozier G, Lipton RB, et al. Lasmiditan is an effective acute treatment for migraine: a phase 3 randomized study. Neurology. 2018;91(24):e2222\u201332.","journal-title":"Neurology."},{"issue":"1","key":"914_CR8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12883-020-01633-3","volume":"20","author":"H Deng","year":"2020","unstructured":"Deng H, Li G, Nie H, Feng Y, Guo G, Guo W, et al. Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine \u2013 an updated systematic review and meta-analysis. BMC Neurol. 2020;20(1):57.","journal-title":"BMC Neurol"},{"key":"914_CR9","doi-asserted-by":"crossref","unstructured":"Yang Y, Chen M, Sun Y, Gao B, Chen Z, Wang Z. Safety and efficacy of ubrogepant for the acute treatment of episodic migraine: a meta-analysis of randomized clinical trials. CNS Drugs. 34:463\u201371.","DOI":"10.1007\/s40263-020-00715-7"},{"issue":"19","key":"914_CR10","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/jama.2019.16711","volume":"322","author":"RB Lipton","year":"2019","unstructured":"Lipton RB, Dodick DW, Ailani J, Lu K, Finnegan M, Szegedi A, et al. Effect of ubrogepant vs placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: the ACHIEVE II randomized clinical trial. JAMA. 2019;322(19):1887\u201398.","journal-title":"JAMA"},{"issue":"4","key":"914_CR11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/head.13766","volume":"60","author":"DW Dodick","year":"2020","unstructured":"Dodick DW, Lipton RB, Ailani J, Halker Singh RB, Shewale AR, Zhao S, et al. Ubrogepant, an acute treatment for migraine, improved patient-reported functional disability and satisfaction in 2 single-attack phase 3 randomized trials, ACHIEVE I and II. Headache. 2020;60(4):686\u2013700.","journal-title":"Headache"},{"issue":"3","key":"914_CR12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1525-1403.1999.00217.x","volume":"2","author":"RL Weiner","year":"1999","unstructured":"Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation. 1999;2(3):217\u201321.","journal-title":"Neuromodulation."},{"issue":"8437","key":"914_CR13","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(85)92413-4","volume":"325","author":"AT Barker","year":"1985","unstructured":"Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;325(8437):1106\u20137 Important to understand the mechanism underlying sTMS.","journal-title":"Lancet"},{"issue":"7","key":"914_CR14","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/brain\/aww118","volume":"139","author":"AP Andreou","year":"2016","unstructured":"Andreou AP, Holland PR, Akerman S, Summ O, Fredrick J, Goadsby PJ. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain. 2016;139(7):2002\u201314 Important to understand the mechanism underlying sTMS.","journal-title":"Brain"},{"issue":"4","key":"914_CR15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1474-4422(10)70054-5","volume":"9","author":"RB Lipton","year":"2010","unstructured":"Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010;9(4):373\u201380 Important trial for approval of sTMS for acute therapy.","journal-title":"Lancet Neurol"},{"key":"914_CR16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1186\/s10194-015-0535-3","volume":"16","author":"R Bhola","year":"2015","unstructured":"Bhola R, Kinsella E, Giffin N, Lipscombe S, Ahmed F, Weatherall M, et al. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain. 2015;16:535.","journal-title":"J Headache Pain."},{"issue":"6","key":"914_CR17","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/0333102418762525","volume":"38","author":"AJ Starling","year":"2018","unstructured":"Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hindiyeh N, et al. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study). Cephalalgia. 2018;38(6):1038\u201348 Important trial for approval of sTMS for preventive therapy.","journal-title":"Cephalalgia"},{"issue":"7","key":"914_CR18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1526-4610.2010.01697.x","volume":"50","author":"DW Dodick","year":"2010","unstructured":"Dodick DW, Schembri CT, Helmuth M, Aurora SK. Transcranial magnetic stimulation for migraine: a safety review. Headache. 2010;50(7):1153\u201363 Important to understand the safety of sTMS.","journal-title":"Headache"},{"issue":"17","key":"914_CR19","first-page":"S312","volume":"23","author":"B Simon","year":"2017","unstructured":"Simon B, Blake J. Mechanism of action of non-invasive cervical vagus nerve stimulation for the treatment of primary headaches. Am J Manag Care. 2017;23(17):S312\u20136 Important to understand the mechanism underlying nVNS.","journal-title":"Am J Manag Care"},{"issue":"9","key":"914_CR20","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/0333102419833076","volume":"39","author":"DJHA Henssen","year":"2019","unstructured":"Henssen DJHA, Derks B, van Doorn M, Verhoogt N, Van Cappellen van Walsum A-M, Staats P, et al. Vagus nerve stimulation for primary headache disorders: An anatomical review to explain a clinical phenomenon. Cephalalgia. 2019;39(9):1180\u201394 Important to understand the mechanism underlying nVNS.","journal-title":"Cephalalgia"},{"key":"914_CR21","doi-asserted-by":"crossref","first-page":"101971","DOI":"10.1016\/j.nicl.2019.101971","volume":"24","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu J, Li H, Yan Z, Liu X, Cao J, et al. Transcutaneous auricular vagus nerve stimulation at 1 Hz modulates locus coeruleus activity and resting state functional connectivity in patients with migraine: an fMRI study. NeuroImage. 2019;24:101971.","journal-title":"NeuroImage"},{"issue":"12","key":"914_CR22","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/0333102414524494","volume":"34","author":"P Goadsby","year":"2014","unstructured":"Goadsby P, Grosberg B, Mauskop A, Cady R, Simmons K. Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia. 2014;34(12):986\u201393.","journal-title":"Cephalalgia."},{"issue":"4","key":"914_CR23","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1212\/WNL.0000000000005857","volume":"91","author":"C Tassorelli","year":"2018","unstructured":"Tassorelli C, Grazzi L, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology. 2018;91(4):e364\u201373 Important trial used for approval of nVNS for acute therapy.","journal-title":"Neurology"},{"issue":"1","key":"914_CR24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s10194-018-0928-1","volume":"19","author":"L Grazzi","year":"2018","unstructured":"Grazzi L, Tassorelli C, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, et al. Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial. J Headache Pain. 2018;19(1):98.","journal-title":"J Headache Pain."},{"issue":"1","key":"914_CR25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s10194-018-0929-0","volume":"19","author":"P Martelletti","year":"2018","unstructured":"Martelletti P, Barbanti P, Grazzi L, Pierangeli G, Rainero I, Geppetti P, et al. Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial. J Headache Pain. 2018;19(1):101.","journal-title":"J Headache Pain"},{"issue":"5","key":"914_CR26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.0000000000002918","volume":"87","author":"SD Silberstein","year":"2016","unstructured":"Silberstein SD, Calhoun AH, Lipton RB, Grosberg BM, Cady RK, Dorlas S, et al. Chronic migraine headache prevention with noninvasive vagus nerve stimulation. Neurology. 2016;87(5):529\u201338.","journal-title":"Neurology."},{"issue":"12","key":"914_CR27","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1177\/0333102419876920","volume":"39","author":"H-C Diener","year":"2019","unstructured":"Diener H-C, Goadsby PJ, Ashina M, Al-Karagholi MA-M, Sinclair A, Mitsikostas D, et al. Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: the multicentre, double-blind, randomised, sham-controlled PREMIUM trial. Cephalalgia. 2019;39(12):1475\u201387.","journal-title":"Cephalalgia"},{"issue":"5","key":"914_CR28","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1212\/WNL.0000000000007857","volume":"93","author":"CF Schroeder","year":"2019","unstructured":"Schroeder CF, M\u00f6ller M, May A. nVNS sham significantly affects the trigeminal-autonomic reflex. Neurology. 2019;93(5):e518\u201321 Important to understand the mechanism underlying nVNS.","journal-title":"Neurology"},{"issue":"1","key":"914_CR29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s10194-015-0582-9","volume":"16","author":"TM Kinfe","year":"2015","unstructured":"Kinfe TM, Pintea B, Muhammad S, Zaremba S, Roeske S, Simon BJ, et al. Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: preliminary findings from a prospective observational cohort study. J Headache Pain. 2015;16(1):101.","journal-title":"J Headache Pain"},{"issue":"9","key":"914_CR30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/0333102416656118","volume":"37","author":"D Magis","year":"2017","unstructured":"Magis D, D\u2019Ostilio K, Thibaut A, De Pasqua V, Gerard P, Hustinx R, et al. Cerebral metabolism before and after external trigeminal nerve stimulation in episodic migraine. Cephalalgia. 2017;37(9):881\u201391 Important to understand the mechanism underlying eTNS.","journal-title":"Cephalalgia"},{"issue":"8","key":"914_CR31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/WNL.0b013e3182825055","volume":"80","author":"J Schoenen","year":"2013","unstructured":"Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, G\u00e9rard P, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80(8):697\u2013704 Important trial for approval of eTNS for preventive therapy.","journal-title":"Neurology"},{"issue":"1","key":"914_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0333102418811573","volume":"39","author":"DE Chou","year":"2019","unstructured":"Chou DE, Shnayderman Yugrakh M, Winegarner D, Rowe V, Kuruvilla D, Schoenen J. Acute migraine therapy with external trigeminal neurostimulation (ACME): a randomized controlled trial. Cephalalgia. 2019;39(1):3\u201314 Important trial for approval of eTNS for acute therapy.","journal-title":"Cephalalgia"},{"issue":"1","key":"914_CR33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1129-2377-14-95","volume":"14","author":"D Magis","year":"2013","unstructured":"Magis D, Sava S, d\u2019Elia TS, Baschi R, Schoenen J. Safety and patients\u2019 satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly\u00ae device in headache treatment: a survey of 2,313 headache sufferers in the general population. J Headache Pain. 2013;14(1):95 Important to understand the safety of eTNS.","journal-title":"J Headache Pain"},{"issue":"7","key":"914_CR34","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/ner.12133","volume":"17","author":"D Risti\u0107","year":"2014","unstructured":"Risti\u0107 D, Ellrich J. Innocuous peripheral nerve stimulation shifts stimulus\u2013response function of painful laser stimulation in man. Neuromodulation. 2014;17(7):686\u201395.","journal-title":"Neuromodulation"},{"issue":"8","key":"914_CR35","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/head.13551","volume":"59","author":"D Yarnitsky","year":"2019","unstructured":"Yarnitsky D, Dodick DW, Grosberg BM, Burstein R, Ironi A, Harris D, et al. Remote electrical neuromodulation (REN) relieves acute migraine: a randomized, double-blind, placebo-controlled, multicenter trial. Headache. 2019;59(8):1240\u201352 Important trial for approval of eTNS.","journal-title":"Headache"},{"issue":"13","key":"914_CR36","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1212\/WNL.0000000000003760","volume":"88","author":"D Yarnitsky","year":"2017","unstructured":"Yarnitsky D, Volokh L, Ironi A, Weller B, Shor M, Shifrin A, et al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology. 2017;88(13):1250\u20135.","journal-title":"Neurology."},{"key":"914_CR37","unstructured":"U.S. Food and Drug Administration. 2019 [cited 2020 Jun 28]. Available from: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf18\/DEN180059.pdf. Accessed 1 June 2020."},{"issue":"10","key":"914_CR38","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/brain\/awn042","volume":"131","author":"M Dieterich","year":"2008","unstructured":"Dieterich M, Brandt T. Functional brain imaging of peripheral and central vestibular disorders. Brain. 2008;131(10):2538\u201352.","journal-title":"Brain."},{"issue":"2","key":"914_CR39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejrad.2008.01.042","volume":"70","author":"V Marcelli","year":"2009","unstructured":"Marcelli V, Esposito F, Aragri A, Furia T, Riccardi P, Tosetti M, et al. Spatio-temporal pattern of vestibular information processing after brief caloric stimulation. Eur J Radiol. 2009;70(2):312\u20136.","journal-title":"Eur J Radiol"},{"issue":"7","key":"914_CR40","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/head.13120","volume":"57","author":"D Wilkinson","year":"2017","unstructured":"Wilkinson D, Ade KK, Rogers LL, Attix DK, Kuchibhatla M, Slade MD, et al. Preventing episodic migraine with caloric vestibular stimulation: a randomized controlled trial. Headache. 2017;57(7):1065\u201387.","journal-title":"Headache"},{"key":"914_CR41","unstructured":"U.S. National Library of Medicine. [cited 2020 Jul 7]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02991430. Accessed 1 June 2020."},{"key":"914_CR42","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1109\/JTEHM.2016.2615899","volume":"4","author":"RD Black","year":"2016","unstructured":"Black RD, Rogers LL, Ade KK, Nicoletto HA, Adkins HD, Laskowitz DT. Non-invasive neuromodulation using time-varying caloric vestibular stimulation. IEEE J Transl Eng Health Med. 2016;4:2168.","journal-title":"IEEE J Transl Eng Health Med"},{"issue":"1","key":"914_CR43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(97)01017-2","volume":"780","author":"DJ Reis","year":"1998","unstructured":"Reis DJ, Kobylarz K, Yamamoto S, Golanov EV. Brief electrical stimulation of cerebellar fastigial nucleus conditions long-lasting salvage from focal cerebral ischemia: conditioned central neurogenic neuroprotection. Brain Res. 1998;780(1):161\u20135.","journal-title":"Brain Res"},{"issue":"2","key":"914_CR44","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0006-8993(98)01169-X","volume":"818","author":"EV Golanov","year":"1999","unstructured":"Golanov EV, Reis DJ. Neuroprotective electrical stimulation of cerebellar fastigial nucleus attenuates expression of periinfarction depolarizing waves (PIDs) and inhibits cortical spreading depression. Brain Res. 1999;818(2):304\u201315.","journal-title":"Brain Res"},{"issue":"13","key":"914_CR45","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1177\/0333102416678623","volume":"37","author":"Y Juan","year":"2017","unstructured":"Juan Y, Shu O, Jinhe L, Na Y, Yushuang D, Weiwei D, et al. Migraine prevention with percutaneous mastoid electrical stimulator: a randomized double-blind controlled trial. Cephalalgia. 2017;37(13):1248\u201356.","journal-title":"Cephalalgia."},{"key":"914_CR46","doi-asserted-by":"publisher","unstructured":"Deng Y, Zheng M, He L, Yang J, Yu G, Wang J. A head-to-head comparison of percutaneous mastoid electrical stimulator and supraorbital transcutaneous stimulator in the prevention of migraine: a prospective, randomized controlled study. Neuromodulation. 2020 [cited 2020 Jul 7]; Available from:. https:\/\/doi.org\/10.1111\/ner.13127.","DOI":"10.1111\/ner.13127"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-020-00914-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-020-00914-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-020-00914-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T22:52:30Z","timestamp":1610664750000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-020-00914-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["914"],"URL":"https:\/\/doi.org\/10.1007\/s11916-020-00914-3","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"20 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"78"}}